Chinese couples using fertility drug to skirt 1-child policy: Knowledge Driven Revolution

Chinese women are turning to the illegal practice of using a fertility drug to exploit a loophole in the country's one-child policy.

Clomiphene citrate is used for women with irregular menstruation, but when a healthy woman takes the tablets, it increases the chances of having twins or triplets.

China's one-child policy prohibits most Chinese people living in cities from having more than one child, but it does not penalize anyone who has a multiple birth.

The drug works by changing brain chemistry to make a women's body release more eggs.

By stimulating multiple births, the drug also helps a woman increase the odds of having a boy, which is valued for carrying on the family line.

The drug is supposed to require a prescription, but is available without one. A three-month supply can be bought for the equivalent of about $1.50.

Despite warnings from Chinese authorities, doctors are seeing a sharp rise in multiple conceptions.

In many cases, women decide during their pregnancies that they don't want twins or triplets. They have one option, said Dr. Ga Ming Je, to abort the unwanted fetuses.

"If the pregnancy is more than two babies, we must reduce," she said.

Aside from the difficulty of giving birth to twins or triplets, women who take the drug face an increased risk of ovarian cancer when it is not used properly. It can also cause ovarian cysts.

Read the full article here

Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking here.

Read Today's Knowledge Driven News
HOME Canadians Should Pay NOT to be Poisoned: NDP V for Vendetta - R for Reality Canadian Bird Flu Pandemic Looming ? Shill of the Week: Stephan Harper Aspartame: The Sweetest Killer Chicken Little Terrorist of the Week: Creating Fake Terrorists Shill of the Week: Paul Martin The Number 1 Reason YOU became a Slave	Chinese couples using fertility drug to skirt 1-child policy CBC News September 29, 2006 Chinese women are turning to the illegal practice of using a fertility drug to exploit a loophole in the country's one-child policy. Clomiphene citrate is used for women with irregular menstruation, but when a healthy woman takes the tablets, it increases the chances of having twins or triplets. China's one-child policy prohibits most Chinese people living in cities from having more than one child, but it does not penalize anyone who has a multiple birth. The drug works by changing brain chemistry to make a women's body release more eggs. By stimulating multiple births, the drug also helps a woman increase the odds of having a boy, which is valued for carrying on the family line. The drug is supposed to require a prescription, but is available without one. A three-month supply can be bought for the equivalent of about $1.50. Despite warnings from Chinese authorities, doctors are seeing a sharp rise in multiple conceptions. In many cases, women decide during their pregnancies that they don't want twins or triplets. They have one option, said Dr. Ga Ming Je, to abort the unwanted fetuses. "If the pregnancy is more than two babies, we must reduce," she said. Aside from the difficulty of giving birth to twins or triplets, women who take the drug face an increased risk of ovarian cancer when it is not used properly. It can also cause ovarian cysts. Read the full article here Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking here. About KDR \| \| Home \| \| Weekly Features Archive	Weekly Features Archive
		What Is Wrong With Canada ? Recent 9-11 News Suppressed by the Media Aspartame: The Sweetest Killer The Number 1 Reason YOU became a Slave Knowledge Driven Look at Your Favourite Canadian Political Parties
		July August September 2006 27 28 29 30 31 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Weekly Features 2006 2005 Read Today's Knowledge Driven News
		Counter
Copyright © 2005-6 KnowledgeDrivenRevolution.com